DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Summary for Patent: 6,428,805
|Title:||Powdery nasal compositions|
|Abstract:||A powdery nasal composition comprising a drug and colloidal cellulose is provided. The composition is a nasal composition providing a superior absorption activity for the drug.|
|Inventor(s):||Dohi; Masahiko (Hino, JP), Uejima; Yasuhide (Hino, JP), Fujii; Takao (Hino, JP)|
|Assignee:||Teijin Limited (Osaka, JP)|
|Patent Claims:||1. A powdery nasal composition comprising a drug and colloidal cellulose, wherein said colloidal cellulose is obtained by spray-drying crystalline cellulose and one or more
viscosity-increasing polymers selected from the group consisting of carboxymethylcellulose, a sodium salt of carboxymethylcellulose, a calcium salt of carboxymethylcellulose, xantha gum, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, and
acrylic acid starch.
2. The powdery nasal composition according to claim 1 wherein said drug is a nonpeptidyl and nonproteinaceous drug or a peptidyl and proteinaceous drug.
3. The powdery nasal composition according to claim 2, wherein said nonpeptidyl and nonproteinaceous drug is one or more of the drugs selected from the group consisting of anti-inflammatory steroids or non-steroidal anti-inflammatory drugs, analgesic anti-inflammatory drugs, antitussive expectorant drugs, anti-histamine drugs, anti-allergic drugs, anti-emetic drugs, hypnotic drugs, vitamins, sex steroid hormones, anti-cancer drugs, anti-arrhythmic drugs, anti-hypertensive drugs, anti-anxiety drugs, psychomimetics, anti-ulcer drugs, cardiac stimulants, analgesics, bronchodilators, anti-obesity drugs, platelet aggregation suppressive drugs, anti-diabetic drugs, muscle relaxants, anti-migraine drugs, and anti-rheumatic drugs.
4. The powdery nasal composition according to claim 2, wherein said peptidyl and proteinaceous drug is one or more of the drugs selected from the group consisting of luteinizing hormone-releasing hormones, growth hormone-releasing factors, somatostatin derivatives, vasopressins, oxytocins, hirudin derivatives, enkephalins, adrenocorticotrophic hormone derivatives, bradykinin derivatives, calcitonins, insulins, glucagon derivatives, growth hormones, growth hormone-releasing hormones, luteinizing hormones, insulin growth hormones, calcitonin gene-related peptides, atrial natriuretic peptide derivatives, interferons, erythropoietins, granulocyte colony-stimulating factor, macrophage forming stimulating factor, parathyroid hormones, parathyroid hormone-releasing hormone, prolactin, thyroid stimulating hormone-releasing hormone, and angiotensins.
5. A powdery nasal composition comprising a drug and colloidal cellulose obtained by spray-drying crystalline cellulose and one or more viscosity-increasing polymers selected from the group consisting of carboxymethylcellulose, a sodium salt of carboxymethylcellulose, a calcium salt of carboxymethylcellulose, xanthan gum, hydroxypropyl Cellulose, hydroxypropyl nethyl cellulose, and acrylic acid starch, wherein said colloidal cellulose is one or more colloidal celluloses selected front the group consisting of Avicel RC-581, Avicel RC-591, and Avicel CL-611.
Summary for Patent: Start Trial
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Japan||10-240242||Aug 26, 1998|
|PCT Filed||August 24, 1999||PCT Application Number:||PCT/JP99/04560|
|PCT Publication Date:||March 09, 2000||PCT Publication Number:||WO00/12136|
|Applicant||Tradename||Biologic Ingredient||Dosage Form||BLA||Number||Approval Date||Patent No.||Assignee||Estimated Patent Expiration||Status||Orphan||Source|
|Jubilant Hollisterstier Llc||POSITIVE SKIN TEST CONTROL - HISTAMINE||histamine||INJECTION||103891||1||1995-06-15||Start Trial||Teijin Limited (Osaka, JP)||2018-08-26||search|
|Nps Pharms Inc||NATPARA||parathyroid hormone||INJECTABLE;INJECTION||125511||001||2015-01-23||Start Trial||Teijin Limited (Osaka, JP)||2018-08-26||RX||Orphan||search|
|Nps Pharms Inc||NATPARA||parathyroid hormone||INJECTABLE;INJECTION||125511||002||2015-01-23||Start Trial||Teijin Limited (Osaka, JP)||2018-08-26||RX||Orphan||search|
|Nps Pharms Inc||NATPARA||parathyroid hormone||INJECTABLE;INJECTION||125511||003||2015-01-23||Start Trial||Teijin Limited (Osaka, JP)||2018-08-26||RX||Orphan||search|
|>Applicant||>Tradename||>Biologic Ingredient||>Dosage Form||>BLA||>Number||>Approval Date||>Patent No.||>Assignee||>Estimated Patent Expiration||>Status||>Orphan||>Source|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.